Silence Therapeutics plc (SLN)

NGM – Real Time Price. Currency in USD

13.70

-1.02 (-6.93%)

Market open: Aug 12, 2026, 2:20 PM EDT

14.75

+0.03 (0.20%)

Previous after-hours: Aug 11, 2026, 7:53 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

560K

43M

32M

22M

Cost of goods sold

-615K

-12M

-13M

-14M

Gross Profit

-55K

31M

19M

Operating expenses (excl. COGS)

-82M

-81M

-71M

-67M

Operating Income

-82M

-50M

-53M

-60M

Non-operating income, total

-6M

-841K

Pretax income

-89M

-44M

-53M

-58M

Equity in earnings

Taxes

-11K

-845K

-960K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-89M

-45M

-54M

-50M

Discontinued operations

Net income

-89M

-45M

-54M

-50M

Dilution adjustment

Preferred dividends

Silence Therapeutics plc (SLN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Silence Therapeutics plc (SLN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Silence Therapeutics plc (SLN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Silence Therapeutics plc (SLN)

Income Statement (Annual)

Income Statement (Annual)